ClinicalTrials.gg
CompletedNCT05688254FOREST-AUpdated May 28, 2024

Internet-Based Stress Recovery Program for Adolescents

An interventional study of FOREST-A in Stress, Psychological, sponsored by Vilnius University. Completed at 1 site in Lithuania. Open to participants aged 15 Years to 19 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-28.

Sponsored by Vilnius University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
15 Years to 19 Years
Sex
All
01

Study summary

The study aims to evaluate the feasibility and efficacy of the internet-based stress recovery program for adolescents.

Read the detailed description

The FOREST-A is a third-wave cognitive behavioral therapy and mindfulness-based internet-delivered 4-week psychosocial intervention for recovery from stress, which was initially developed for healthcare workers and is now adapted for adolescents. The program comprises six modules: introduction, relaxation, psychological detachment, mastery, control, and summary, with psychologist engagement on-demand. Each module includes psychoeducation and exercises. The program will be delivered in Lithuanian.

The intervention will be evaluated using the two-arm randomized controlled trial with intervention and care as usual condition at pre-test and post-test.

02

Conditions studied

  • Stress, Psychological

Browse trials for

03

In context

Stress, Psychological

806 studies on the registry are indexed under Stress, Psychological; 131 are open to participants now.

This study's enrollment of 82 is close to the median of 84 across 651 interventional studies indexed under Stress, Psychological.

Browse Stress, Psychological studies →

Lead sponsor

Vilnius University is the lead sponsor of 61 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Recent exposure to life-stressor.
  • Students of high schools in Lithuania.
  • Comprehending Lithuanian.
  • Parental and own consent for minor-aged participants (\< 18 years)/only own consent for adolescents aged 18 years or older to participate in the study provided.
  • Have access to a device (such as a tablet, phone or computer) with an internet connection.

Exclusion criteria

Exclusion Criteria:

  • Acute psychiatric condition/crisis.
  • No recent life-stressor exposure, or low levels of stress.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
82 participants (actual)

Study arms

  • Experimental
    Intervention group

    The intervention group will get a 4-week online stress recovery intervention.

    Behavioral: FOREST-A

  • No intervention
    Control group

    The control group will take care as usual.

Interventions

  • BehavioralFOREST-A

    The internet-based psychosocial intervention will be delivered. The intervention comprises six modules: introduction, relaxation, psychological detachment, mastery, control, and summary, within psychoeducation and exercises in each module. The interactions with psychologists will be on demand. The whole intervention duration will be 4 weeks.

06

What researchers measure

Primary outcomes

  1. The Recovery Experience Questionnaire

    The Recovery Experience Questionnaire (Sonnentag \& Fritz, 2007) adapted Child and Adolescent version will be used to measure the changes in recovery from stress experience. It is a self-report measure comprising 16 items, with provided 5-point Likert scale, ranging from Totally disagree (=1) to Totally agree (=5). Total scores may range from 16 to 80, and higher scores will indicate higher recovery.

    Time frame: Pre-treatment, post-treatment (after 4 weeks), 3 months follow-up

Secondary outcomes

  1. The Adjustment Disorder New Module-8 Child and Adolescent Version Questionnaire

    The Adjustment Disorder New Module-8 Child and Adolescent Version (Kazlauskas et al., 2018) will be used to measure the changes in symptoms of adjustment disorder, which are described in the International Classification of diseases 11th edition (WHO, 2018). The measure includes a list of 16 potentially stressful events (with binary answers Yes and No, indicating whether the participant has experienced a stressor) and 8 items for adjustment disorder symptoms evaluation (with a 4-point Likert scale ranging from Never (=1) to Often (=4)). Total scores may range from 8 to 32, and higher scores will indicate higher adjustment problems.

    Time frame: Pre-treatment, post-treatment (after 4 weeks), 3 months follow-up

  2. The Generalized Anxiety Disorder-7 scale

    The Generalized Anxiety Disorder-7 scale (Spitzer, Kroenke, Williams, \& Löwe, 2007) will be used to measure the changes in generalized anxiety symptoms.The measure comprises 7 items with the possible answers ranging on a 4-point Likert scale from Not at all (=0) to Nearly every day (=3). Total scores may range from 0 to 21. Higher scores will indicate higher generalized anxiety symptoms.

    Time frame: Pre-treatment, post-treatment (after 4 weeks), 3 months follow-up

  3. The Patient Health Questionnaire-9 questionnaire

    The Patient Health Questionnaire-9 (Löwe, Kroenke, Herzog, \& Gräfe, 2004) will be used to measure changes in depressive symptoms. The measure comprises 9 items, with provided a 4-point Likert scale, ranging from Not at all (=0) to Nearly every day (=3). Total scores may range from 0 to 27. Higher scores will indicate higher depressive symptoms.

    Time frame: Pre-treatment, post-treatment (after 4 weeks), 3 months follow-up

  4. The WHO-5 Well-being Index Questionnaire

    The WHO-5 Well-being Index (Topp, Østergaard, Søndergaard, \& Bech, 2015) will be used to measure changes in general psychological well-being. The measure comprises 5 items with a Likert scale ranging At no time (=0) to All of the time (=5). Total scores may range from 0 to 25. Higher scores will indicate better psychological well-being.

    Time frame: Pre-treatment, post-treatment (after 4 weeks), 3 months follow-up

  5. The Perceived Positive Social Support Scale

    The Perceived Positive Social Support Scale (Kazlauskas et al., 2022) will be used to measure changes in social support. The measure comprises 4 items, with provided an 8-point Likert scale ranging from Never (=0) to Always (=7). Total scores may range from 0 to 28. Higher scores will indicate higher perceived positive support.

    Time frame: Pre-treatment, post-treatment (after 4 weeks), 3 months follow-up

Other outcomes

  1. Program evaluation questions

    Participants will be given questions regarding the usage, general satisfaction, usefulness of the program, and subjective impact on psychological and physical well-being.

    Time frame: Post-treatment (after 4 weeks)

07

Study locations

1 site
  • Vilnius University
    Vilnius, Lithuania
08

References and documents

Publications

  • Zelviene P, Kairyte A, Dumarkaite A, Nomeikaite A, Kazlauskas E. Internet-based stress recovery intervention for adolescents: study protocol for a randomized controlled trial. Trials. 2023 Mar 8;24(1):174. doi: 10.1186/s13063-023-07188-1. PubMed 36890560 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2023 to primary completion in Jun 2023, 2 months.

Of 444 non-industry interventional studies with no phase under Stress, Psychological, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's 2 months is below that.

Counting every sponsor, half of 456 studies reached it within 13 months; a quarter within 5 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 8, 2023
First posted
Jan 18, 2023
StartActual
Apr 25, 2023
Primary completionActual
Jun 30, 2023
CompletionActual
Jun 30, 2023
Last update
May 28, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05688254
Lead sponsor
Vilnius University
Responsible party
Sponsor
First posted
Jan 18, 2023
Start date
Apr 25, 2023
Primary completion
Jun 30, 2023
Completion
Jun 30, 2023
Last update
May 28, 2024

Study contacts

Paulina Zelviene, PhD
principal investigator · Vilnius University, Institute of Psychology

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion